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Conclusions The gentamicin Vd cannot be predicted by age, the
presence of renal failure or any studied comorbidities. Therefore, in
order to obtain adequate therapeutic levels as soon as possible, a
high first gentamicin dose (that is, at least 7 mg/kg) should be
given to all patients. In women, even higher doses may be needed.
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Introduction The Surviving Sepsis Campaign Guideline 2008 [1]
recommends starting appropriate antibiotic therapy within 1 hour
after making the diagnosis of septic shock. In the ICU of our
emergency center, we perform empiric antibiotic therapy for septic
shock patients within 6 hours after admission.
Methods Cases of severe sepsis or septic shock diagnosed and
treated in the ICU of our emergency center for more than 48 hours
between January 2005 and September 2008 were retrospectively
analyzed. The cases were divided into a survival group and a
nonsurvival group, and were compared in relation to primary
diagnosis, clinical findings, and type of pathogen. The chi-square
test and paired t test were used to perform the statistical analysis.
Results There were 107 cases, 24 cases of severe sepsis and 83
cases of septic shock, and 73 of them were in males. The mean and
standard deviation of the patients’ age was 66.4 ± 15 years. The
severity of their illness according to the APACHE II score was 22.3 ±
8, and their Sequential Organ Failure Assessment score was 9.1 ± 4.
The causes of the sepsis were pneumonia (51.4%), peritonitis
(13.1%), and soft tissue infection (13.1%). Mortality was 26.2%.
There were 79 cases in the survival group and 28 in the nonsurvival
group. The two groups are presented in Table 1. We performed a
multivariate regression analysis to identify prognostic factors, and the
only independent prognostic factors were age (OR = 0.955
(P = 0.022; 95% CI = 0.91 to 0.99)), acute respiratory disease
syndrome (ARDS) (OR = 5.789 (P = 0.002; 95% CI = 1.91 to 17.4))
and base deficit (OR = 1.113 (P = 0.008; 95% CI = 1.02 to 1.2)).
Early appropriate antibiotic therapy (EAAT) was not correlated with
survival.
Table 1 (abstract P320)
Survival Nonsurvival P value
Early appropriate antibiotic therapy (%) 67 60.7 0.645
Gram-positive coccus (%) 39.2 53.5 0.297
Gram-negative rod (%) 29.1 39.2 0.351
Conclusions EAAT did not affect the outcome. The prognostic
factors for severe sepsis and septic shock identified in this study
were age, base deficit and ARDS.
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Introduction Airway aspiration (AWA) of gastric content is a very
frequent complication in patients presenting to emergency rooms
after incidents linked to a depressed level of consciousness. The
routine use of antibiotics in this situation determines a high-
pressure selection for multiresistant microorganisms. However,
how often AWA is the causative situation for early ventilator-
associated pneumonia is not known. Also a gold standard for a
diagnostic workup is needed. Our aim was to know how frequent
AWA determines infectious aspiration pneumonia confirmed by
evolution and microbiological samples, and to propose a
methodological approach to rule out antibiotic usage.
Methods Over a 2-year period, in 82 patients admitted to our ICU,
AWA was confirmed by the direct observation of gastric content
when orotracheal intubation was performed by a trained physician
due to a Glasgow coma scale below 12. Usual diagnosis: acute
brain injury, 52 patients (73%); Simplified Acute Physiology Score
II 37 ± 11; age, 44 ± 15 years; all were mechanically ventilated,
average 6 ± 2 days; ICU stay ± 10 days; mortality 21%. Rectal
fever, leukocytosis, thoracic radiology and PaO2/FiO2 were recorded
on a daily basis. The Clinical Pulmonary Infection Score (CPIS) and
semiquantitative tracheal aspirates (SQTA) were performed twice: in
the first 48 hours and between the third and fifth days.
Results Out of 82 patients, 23 (28%) developed clinically and
microbiologically confirmed pneumonia. Fever and leukocytosis
showed no significant differences in patients with or without
pneumonia during the first 5 days. Also the PaO2/FiO2 index was
not different. As for radiology, when unilateral focal condensation
was present, pneumonia was confirmed later (relative risk = 3.3,
95% CI = 1.7 to 6.4). CPIS in the first 48 hours showed a negative
predictive value for pneumonia of 89%, and SQTA with no
microorganism growth a negative predictive value of 96%. In our
patient group, 42 (51%) had CPIS <6 and SQTA growth; in them
no antibiotic usage is recommended. On the contrary, out of 20
patients who had CPIS ≥6 and positive SQTA, 16 (75%) developed
pneumonia within the first 5 days of the ICU stay; this group
deserves antibiotics. CPIS ≥6 without pneumonia, probably due to
lung inflammation, was observed in 10 out of 28 patients (36%).
Conclusions (1) In our ICU population, pneumonia develops in
only 28% of those presenting with AWA. (2) Through CPIS <6
and negative SQTA performed in the first 48 hours we could
identify that in more than one-half of AWA patients antibiotics are
not needed. (3) CPIS is not a reliable early indicator of pneumonia
in patients with AWA.
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Introduction The proinflammatory cytokine TNF plays a critical role
in the formation of severe sepsis when it is excessively released.
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Recently, it was revealed through our animal models that intra-
venous administration of freeze-dried sulfonated human normal
immunoglobulin (IVIG) makes anti-inflammatory effects by
enhancing insulin-like growth factor 1 (IGF-1) production through
stimulation of sensory nerves, which inhibits the production of TNF.
In this study, we examined whether IVIG for septic patients
enhances IGF-1 production.
Methods Fourteen septic patients indicating a high level of soluble
E-selectin were surveyed, who were transported to our hospital
from April to November 2007. They were divided into two groups,
IVIG group (G-group, 5 g/day x 3 days, nine cases, 67.2 ± 8.64
years old) and nonadministered group (control group, C-group, five
cases, 69 ± 12.9 years old).
Results In the G-group, the values of IGF-1 on the fifth day
(162.22 ± 52.91 ng/ml) and seventh day (150.44 ± 29.06 ng/ml)
were significantly higher than that on day 0 (88.59 ± 29.79 ng/ml,
P <0.05). Furthermore, The value of IGF-1 of the G-group
(162.22 ± 52.91 ng/ml) was significantly higher than that of the C-
group (68.80 ± 24.04 ng/ml) on the fifth day (P <0.05).
Conclusions We revealed that IVIG for septic patients enhances
IGF-1 production. Furthermore we will enhance the effect of
sulfanated immunoglobulin compared with that of intact immuno-
globulin in the difference of the anti-inflammatory effect and the
mechanism.
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Introduction It is known that severe sepsis causes multiple organ
failure and high mortality. Intravenous immunoglobulin (IVIG) is
used for severe sepsis patients. The mechanism of IVIG is clearly
unknown. Suggested, however, is the possibility that IVIG prevents
organic injury by suppressing the inflammation. Soluble fibrin (SF)
is intermediate between fibrinogen and fibrionoligomer. It is better
than fibrinogen as the material for thrombin. IVIG is used as one of
the effective factors for repair of the damaged vascular endo-
thelium. In this study we used SF as a marker of severity of illness
in patients with or without IVIG and compared the levels of SF in
two groups.
Methods Nineteen severe septic patients were divided into two
groups. The control group (n = 9) was not given and the other
group (n = 10) was given IVIG (5 g/day for 3 days). SF of serum
from patients was measured on 0 days, 1 day, 3 days, 5 days and
7 days, and the results were analyzed.
Results The levels of SF were: control group: 4.77 ± 9.44
(0 days), 3.13 ± 2.53 (1 day), 3.33 ± 2.75 (3 days), 2.53 ± 2.58
(5 days), 2.58 ± 3.75 (7 days); other group: 7.71 ± 8.28 (0 days),
12.26 ± 16.75 (1 day), 14.34 ± 25.56 (3 days), 8.06 ± 9.08
(5 days), 11.95 ± 12.71 (7 days). There was a significant
difference in the levels of SF between groups with and without
IVIG at 1 day, 5 days and 7 days.
Conclusions Monocyte has the Fcγ receptor. It is thought that
stimulating Fcγ of monocyte with IgG plays a role in increasing SF.
Without severe DIC, increasing fibrin is used in the repair of the
damaged vascular endothelium as a matrix and it prevents the
invasion of germs. It is thought that increasing fibrin is the
appropriate stimulation for coagulation and one of the reactions of
biomechanical defense. We think SF is one of the important
factors for the damaged cell and a useful marker of severity for
severe sepsis. We also think IVIG is effective for severe sepsis.
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Introduction Previous studies have recommended the use of low-
dose corticosteroids in patients with septic shock. Specifically,
response to corticotropin tests has been recognized as a
prognostic factor in critically ill patients, especially in patients with
no response to the corticotropin test. A recent large randomized
controlled trial evaluating the efficacy of low-dose corticosteroids
revealed no benefit on overall survival or in patients with no
response to corticotropin in patients with severe sepsis and septic
shock. Recently, recommendations for the diagnosis and manage-
ment of corticosteroid insufficiency in critically ill adult patients
were published as consensus statements from an international task
force by the American College of Critical Care Medicine [1].
However, some studies were not included in these statements.
Methods We conducted a systematic search of EMBASE and
MEDLINE (through August 2008) for double-blind randomized
clinical trials that evaluated the effect of corticosteroids on
mortality in patients with severe sepsis and septic shock. Study
selection criteria were all trials before August 2008 in which
participants were randomized to corticosteroids or placebo and in
which mortality was reported.
Results Data from 17 randomized, controlled trials with a total of
3,638 participants were analyzed. Corticosteroid use was not
associated with a risk reduction in overall mortality (pooled risk
ratio = 0.99 (95% CI = 0.90 to 1.09), P = 0.823). Low-dose
corticosteroids (150 to 300 mg/day) did not show benefit on all-
cause mortality in patients with severe sepsis and septic shock
(risk ratio = 0.92 (95% CI = 0.79 to 1.06)). Furthermore, low-dose
corticosteroids in patients with severe sepsis and septic shock
who did not respond to the corticotropin test showed no benefit on
28-day mortality (risk ratio = 0.91 (95% CI = 0.76 to 1.09)).
Corticosteroids use was not associated with increased compli-
cations, such as gastrointestinal bleeding or increased infections.
Conclusions This meta-analysis indicated that administration of
low-dose corticosteroids was not beneficial on overall mortality in
patients with severe sepsis or septic shock.
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